The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage

Journal of Clinical Immunology

Volumn 17, Issue 2, 1997, Pages 140-153

  Jin, Yide ^a   Fuller, Laphalle ^a   Carreno, Manuel ^a   Zucker, Keith ^a   Roth, David ^a   Esquenazi, Violet ^a   Karatzas, Theodore ^a   Swanson III, Sidney J ^b   Tzakis, Andreas G ^a   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

end stage liver disease; hepatitis C virus; intermediate T cells; liver infiltrating lymphocytes

Indexed keywords

CD3 ANTIGEN; CYTOKINE; HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER INJURY; LYMPHOCYTIC INFILTRATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD95; APOPTOSIS; CYTOKINES; HEPACIVIRUS; HEPATITIS C; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER FAILURE; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 8244239686     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027326415164     Document Type: Article

References (24)

1. Zucker K, Roth D, Cirocco R, Mathew J, Carreno M, Fuller L, Karatzas T, Jin Y, Burke G, Nery J, Webb M, Tzakis A, Esquenazi V, Miller J: Transplant-associated autoimmune mechanism in human hepatitis C virus infection. J Clin Immunol 16:60-70, 1996
2. Koziel MJ Dudley D, Afdhal N, Choo O-L, Hougton M, Ralston R, Walker BD: Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67:7522-7532, 1993
3. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H: Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 68:1494-1500, 1994
4. Koziel MJ, Dudley D, Afdhal N, Grakoni A, Rice CM, Choo O-L, Hougton M, Walker BD: HLA class I-restricted cytotoxic T lymphocytes specific tor hepatitis C virus. J Clin Invest 96:2311-2321, 1995
5. Weiner A, Erickson AL, Kansopon J, Crawferd K, Muchmore E, Hughes AL, Houghton M, Walker CM: Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 92:2755-2756, 1995
6. Montelli M, Manns M, Ferrari C: Does the immune response play a role in the pathogenesis of chronic liver disease. Arch Pathol Lab Med 112:489-497, 1988
7. MacDonald RH: NK1.1+ T cell receptor-αβ+ cells: New clues to their origin, specificity, and function. J Exp Med 182:633-638, 1995
8. Vicari AP, Zlotnik Z: Mouse NK1.1+ T cells: A new family of T cells. Immunol Today 17:71-76, 1996
9. Yoshimoto T, Paul WE: CD4+ NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179:1285-1295, 1994
10. NK cells: NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice. J Immunol 149: 403-412, 1992
11. Eichelberger M, Doherty PC: γδT cells from influenza-infected mice develop a natural killer phenotype following culture. Cell Immunol 159:94-102, 1994
12. Ohtek T, MacDonald R: Major histocompatihility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-αβ+ cells in the livers of mice. J Exp Med 180:699-704, 1994
13. Galle PR, Hofmann WJ, Walezak H, Schaller H, Otto G, Strommel W, Krammer PH, Runkel L: Involvement of CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230, 1995
14. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kaschara A, Fusamoto H, Kamata T: Role of fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Brophy Res Commun 204: 468-473, 1994
15. Ranjan D, Roth D, Esquenazi V, Carreno M, Fuller L, Leif R, Burke G, Miller J: The effects of tissue-associated and MHC class II antigen presentation on in vitro lymphoproliferative responses against canine liver and kidney cell subpopulations. Transplantation 51:475-480, 1991
16. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton D, Feinstone SM, Berzofsky JA: An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68:3334-3342, 1994
17. Chakrabarti SM, Robert-Guroff M, Wong-Staal F, Gallo RC, Moss B: Expression of HTLV III envelope gene by a recombinant vaccinia virus. Nature (London) 320:535-537, 1986
18. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB: Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C and intercellular adhesion-1 molecule. J Clin Invest 95: 2067-2075, 1995
19. Nouri-Aria KT, Sallie R, Mizokami M, Portman C, Williams R: Intrahepatic expression of hepatitis C virus antigens in chronic liver disease. J Pathol 175:77-83, 1995
20. Blight K, Lesniewski RR, Labrooy JT, Gowans EJ: Detection and distribution of hepatitis C-specific antigen in naturally infected liver. Hepatology 20:553-557, 1994
21. Kagi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathway as major mechanism of T cell-mediated cytotoxicity. Science 265:528-530, 1994
22. Rouvier E, Luciani M-F, Golstein P: Fas involvement in Ca+ independent T cell-mediated cytotoxicity. J Exp Med 177:195-200, 1993
23. Lemon S, Brown E: Hepatitis C virus and chronic liver disease. In Current Clinical Topics in Infectious Disease, Vol 14, MN Swartz, JS Remington (eds). Cambridge, MA, Blackwell Scientific, 1994, pp 121-141
24. Thornton AJ, Stricter RM, Lindley I, Baggiolini M, Kunkel SL: Cytokine-induced gene expression of a neutrophil chemotactic factor IL-8 in human hepatocytes. J Immunol 144:2609-2613, 1990